AYTU logo

Aytu BioPharma (AYTU) Operating Profit

Annual Operating Profit

-$2.89 M
+$9.44 M+76.57%

June 30, 2024

Summary

Performance

1-Year Change

+76.57%

3-Year Change

+92.45%

5-Year Change

+82.85%

15-Year Change

+84.68%

AYTU Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.87%
AYTU annual operating income is higher than 78.87% of companies in Healthcare sector

High & Low

All-time High

-$46.90 K

3-Year Low

-$38.24 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
AYTU previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
AYTU next annual earnings announcement has not yet been scheduled

OtherAYTUprofitabilitymetrics:

Annual Operating Margin

-3.57%
AYTU annual operating profit margin is -3.57%

Annual Revenue

$81.00 M
AYTU annual revenue is $81.00 million

Annual Net Income

-$15.84 M
AYTU annual net profit is -$15.84 million

Annual EPS

-$2.86
AYTU annual earnings per share is -$2.86

Quarterly Operating Profit

-$146.00 K
+$1.38 M+90.45%

September 30, 2024

Summary

Performance

3-Month Change

+90.45%

1-Year Change

+83.16%

3-Year Change

+98.23%

5-Year Change

+99.03%

AYTU Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.25%
AYTU quarterly operating income is higher than 78.25% of companies in Healthcare sector

High & Low

All-time High

$2.81 M
AYTU quarterly operating income is currently -105.20% below its historical high of $2.81 million

3-Year Low

-$11.29 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUprofitabilitymetrics:

Quarterly Operating Margin

-0.88%
AYTU quarterly operating profit margin is -0.88%

Quarterly Revenue

$16.57 M
AYTU quarterly revenue is $16.57 million

Quarterly Net Income

$1.47 M
AYTU quarterly net profit is $1.47 million

Quarterly EPS

-$0.15
AYTU quarterly earnings per share is -$0.15

TTM Operating Profit

-$1.53 M
+$721.00 K+32.02%

September 30, 2024

Summary

Performance

3-Month Change

+32.02%

1-Year Change

+86.74%

3-Year Change

+96.44%

5-Year Change

+94.52%

AYTU TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.1%
AYTU TTM operating income is higher than 79.1% of companies in Healthcare sector

High & Low

All-time High

$2.09 M
AYTU TTM operating income is currently -173.39% below its historical high of $2.09 million

3-Year Low

-$50.02 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUprofitabilitymetrics:

Annual Operating Margin

-3.57%
AYTU annual operating profit margin is -3.57%

TTM Revenue

$75.48 M
AYTU TTM revenue is $75.48 million

TTM Net Income

-$6.25 M
AYTU TTM net profit is -$6.25 million

TTM EPS

-$1.53
AYTU TTM earnings per share is -$1.53

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$2.89 M
AYTU annual operating income is -$2.89 million

Annual Gross Profit

$54.59 M
AYTU annual gross profit is $54.59 million

Annual Operating Expenses

$57.48 M
AYTU annual total operating expenses is $57.48 million

AYTU Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+76.6%+83.2%+86.7%
3 y3 years+92.5%+98.2%+96.4%
5 y5 years+82.8%+99.0%+94.5%

AYTU Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+92.5%-105.2%+98.7%-173.4%+96.9%
5 y5-yearat high+92.5%-105.2%+99.1%-173.4%+96.9%
alltimeall time-6059.9%+92.5%-105.2%+99.1%-173.4%+96.9%

Aytu BioPharma Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$146.00 K(-90.5%)
-$1.53 M(-32.0%)
Jun 2024
-$2.89 M(-76.6%)
-$1.53 M(-31.1%)
-$2.25 M(-208.0%)
Mar 2024
-
-$2.22 M(-193.9%)
$2.09 M(-141.8%)
Dec 2023
-
$2.36 M(-372.7%)
-$4.99 M(-56.8%)
Sep 2023
-
-$867.00 K(-130.9%)
-$11.54 M(-6.4%)
Jun 2023
-$12.33 M(-65.9%)
$2.81 M(-130.2%)
-$12.33 M(-44.6%)
Mar 2023
-
-$9.29 M(+121.6%)
-$22.24 M(-0.7%)
Dec 2022
-
-$4.19 M(+153.7%)
-$22.41 M(-24.1%)
Sep 2022
-
-$1.65 M(-76.7%)
-$29.51 M(-18.3%)
Jun 2022
-$36.10 M(-5.6%)
-$7.10 M(-24.9%)
-$36.10 M(-18.8%)
Mar 2022
-
-$9.46 M(-16.2%)
-$44.45 M(-11.1%)
Dec 2021
-
-$11.29 M(+37.0%)
-$50.02 M(+16.4%)
Sep 2021
-
-$8.25 M(-46.6%)
-$42.99 M(+12.2%)
Jun 2021
-$38.24 M(+113.4%)
-$15.45 M(+2.8%)
-$38.30 M(+37.1%)
Mar 2021
-
-$15.03 M(+252.5%)
-$27.94 M(+60.6%)
Dec 2020
-
-$4.26 M(+19.8%)
-$17.40 M(-3.9%)
Sep 2020
-
-$3.56 M(-30.2%)
-$18.10 M(-6.1%)
Jun 2020
-$17.92 M(+6.4%)
-$5.09 M(+13.7%)
-$19.28 M(+2.7%)
Mar 2020
-
-$4.48 M(-9.8%)
-$18.77 M(+1.0%)
Dec 2019
-
-$4.97 M(+4.9%)
-$18.58 M(+2.3%)
Sep 2019
-
-$4.74 M(+3.4%)
-$18.16 M(+7.8%)
Jun 2019
-$16.85 M(-5.6%)
-$4.58 M(+6.5%)
-$16.85 M(+4.7%)
Mar 2019
-
-$4.30 M(-5.5%)
-$16.09 M(-7.9%)
Dec 2018
-
-$4.55 M(+33.2%)
-$17.46 M(+3.3%)
Sep 2018
-
-$3.42 M(-10.7%)
-$16.91 M(-5.3%)
Jun 2018
-$17.84 M(-5.4%)
-$3.83 M(-32.5%)
-$17.85 M(-0.0%)
Mar 2018
-
-$5.67 M(+42.0%)
-$17.85 M(+4.8%)
Dec 2017
-
-$3.99 M(-8.3%)
-$17.04 M(-1.2%)
Sep 2017
-
-$4.36 M(+13.6%)
-$17.25 M(-8.5%)
Jun 2017
-$18.86 M(+32.8%)
-$3.83 M(-21.1%)
-$18.86 M(-9.4%)
Mar 2017
-
-$4.86 M(+15.7%)
-$20.82 M(+8.5%)
Dec 2016
-
-$4.20 M(-29.6%)
-$19.19 M(+6.6%)
Sep 2016
-
-$5.97 M(+2.9%)
-$18.01 M(+26.8%)
Jun 2016
-$14.20 M(+86.1%)
-$5.80 M(+79.7%)
-$14.20 M(+34.6%)
Mar 2016
-
-$3.23 M(+7.1%)
-$10.56 M(+15.6%)
Dec 2015
-
-$3.01 M(+39.3%)
-$9.13 M(+48.6%)
Sep 2015
-
-$2.16 M(+0.6%)
-$6.14 M(+53.9%)
DateAnnualQuarterlyTTM
Jun 2015
-$7.63 M(>+9900.0%)
-$2.15 M(+19.1%)
-$3.99 M(+115.5%)
Mar 2015
-
-$1.81 M(>+9900.0%)
-$1.85 M(+3876.2%)
Feb 2015
-
-$9400.00(-38.6%)
-$46.60 K(-19.4%)
Nov 2014
-
-$15.30 K(+41.7%)
-$57.80 K(+0.5%)
Aug 2014
-$57.50 K(-99.1%)
-$10.80 K(-2.7%)
-$57.50 K(+3.0%)
Jun 2014
-$6.35 M(>+9900.0%)
-
-
May 2014
-
-$11.10 K(-46.1%)
-$55.80 K(-1.6%)
Feb 2014
-
-$20.60 K(+37.3%)
-$56.70 K(+16.4%)
Nov 2013
-
-$15.00 K(+64.8%)
-$48.70 K(-7.2%)
Aug 2013
-$52.40 K(-7.1%)
-$9100.00(-24.2%)
-$52.50 K(-13.4%)
May 2013
-
-$12.00 K(-4.8%)
-$60.60 K(+1.5%)
Feb 2013
-
-$12.60 K(-33.0%)
-$59.70 K(+6.0%)
Nov 2012
-
-$18.80 K(+9.3%)
-$56.30 K(-0.2%)
Aug 2012
-$56.40 K(-57.8%)
-$17.20 K(+55.0%)
-$56.40 K(-48.7%)
May 2012
-
-$11.10 K(+20.7%)
-$109.90 K(-7.5%)
Feb 2012
-
-$9200.00(-51.3%)
-$118.80 K(-12.6%)
Nov 2011
-
-$18.90 K(-73.3%)
-$135.90 K(+1.7%)
Aug 2011
-$133.60 K(+135.6%)
-$70.70 K(+253.5%)
-$133.60 K(+75.8%)
May 2011
-
-$20.00 K(-24.0%)
-$76.00 K(+8.9%)
Feb 2011
-
-$26.30 K(+58.4%)
-$69.80 K(+27.4%)
Nov 2010
-
-$16.60 K(+26.7%)
-$54.80 K(-3.4%)
Aug 2010
-$56.70 K(+1.6%)
-$13.10 K(-5.1%)
-$56.70 K(+5.0%)
May 2010
-
-$13.80 K(+22.1%)
-$54.00 K(+10.2%)
Feb 2010
-
-$11.30 K(-38.9%)
-$49.00 K(-7.2%)
Nov 2009
-
-$18.50 K(+77.9%)
-$52.80 K(-5.4%)
Aug 2009
-$55.80 K(+1.5%)
-$10.40 K(+18.2%)
-$55.80 K(-2.4%)
May 2009
-
-$8800.00(-41.7%)
-$57.20 K(-12.9%)
Feb 2009
-
-$15.10 K(-29.8%)
-$65.70 K(+7.4%)
Nov 2008
-
-$21.50 K(+82.2%)
-$61.20 K(+11.5%)
Aug 2008
-$55.00 K(+17.3%)
-$11.80 K(-31.8%)
-$54.90 K(+1.1%)
May 2008
-
-$17.30 K(+63.2%)
-$54.30 K(+7.1%)
Feb 2008
-
-$10.60 K(-30.3%)
-$50.70 K(-8.0%)
Nov 2007
-
-$15.20 K(+35.7%)
-$55.10 K(+17.5%)
Aug 2007
-$46.90 K
-$11.20 K(-18.2%)
-$46.90 K(+31.4%)
May 2007
-
-$13.70 K(-8.7%)
-$35.70 K(+49.4%)
Feb 2007
-
-$15.00 K(+114.3%)
-$23.90 K(+168.5%)
Nov 2006
-
-$7000.00(+268.4%)
-$8900.00(+368.4%)
May 2006
-
-$1900.00
-$1900.00

FAQ

  • What is Aytu BioPharma annual operating income?
  • What is the all time high annual operating profit for Aytu BioPharma?
  • What is Aytu BioPharma annual operating profit year-on-year change?
  • What is Aytu BioPharma quarterly operating income?
  • What is the all time high quarterly operating profit for Aytu BioPharma?
  • What is Aytu BioPharma quarterly operating profit year-on-year change?
  • What is Aytu BioPharma TTM operating income?
  • What is the all time high TTM operating profit for Aytu BioPharma?
  • What is Aytu BioPharma TTM operating profit year-on-year change?

What is Aytu BioPharma annual operating income?

The current annual operating profit of AYTU is -$2.89 M

What is the all time high annual operating profit for Aytu BioPharma?

Aytu BioPharma all-time high annual operating income is -$46.90 K

What is Aytu BioPharma annual operating profit year-on-year change?

Over the past year, AYTU annual operating income has changed by +$9.44 M (+76.57%)

What is Aytu BioPharma quarterly operating income?

The current quarterly operating profit of AYTU is -$146.00 K

What is the all time high quarterly operating profit for Aytu BioPharma?

Aytu BioPharma all-time high quarterly operating income is $2.81 M

What is Aytu BioPharma quarterly operating profit year-on-year change?

Over the past year, AYTU quarterly operating income has changed by +$721.00 K (+83.16%)

What is Aytu BioPharma TTM operating income?

The current TTM operating profit of AYTU is -$1.53 M

What is the all time high TTM operating profit for Aytu BioPharma?

Aytu BioPharma all-time high TTM operating income is $2.09 M

What is Aytu BioPharma TTM operating profit year-on-year change?

Over the past year, AYTU TTM operating income has changed by +$10.01 M (+86.74%)